Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03252314 · ClinicalTrials.gov registry record
Ruptured Aneurysms Treated With Hydrogel Coils
A clinical trial of Ruptured Aneurysm, sponsored by Microvention-Terumo.
- Active
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03252314: Active study of Ruptured Aneurysm, sponsored by Microvention-Terumo.
NCT03252314 is a study of Ruptured Aneurysm that is active but no longer recruiting, run by Microvention-Terumo. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03252314, a study of Ruptured Aneurysm, is active but no longer recruiting, sponsored by Microvention-Terumo.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine safety and occlusion rates when second-generation hydrogel coils are used in the treatment of ruptured intracranial aneurysms.
Conditions Studied
Interventions
- DEVICE Second-generation hydrogel coils
Study Locations (1)
Tennessee
- Methodist University Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2025-12 |
What the registry record for NCT03252314 still lists
NCT03252314 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Ruptured Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Second-generation hydrogel coils is the first listed.
NCT03252314 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03252314 about?
NCT03252314 is a clinical study titled "Ruptured Aneurysms Treated With Hydrogel Coils". To determine safety and occlusion rates when second-generation hydrogel coils are used in the treatment of ruptured intracranial aneurysms.
What is the current status of trial NCT03252314?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2017-11-27. Estimated completion is 2025-12.
What conditions does trial NCT03252314 study?
This clinical trial studies the following conditions: Ruptured Aneurysm.
What interventions are being tested in trial NCT03252314?
The interventions under investigation include: Second-generation hydrogel coils (DEVICE).
Who is sponsoring clinical trial NCT03252314?
This trial is sponsored by Microvention-Terumo, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03252314 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI